HAYLEY MAISLOS: Open Payments
NPI 1225292527 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,161 in 130 payments from 18 companies in 2025. Trend: 2023 $2,838 · 2024 $2,518 · 2025 $3,161
Food & beverage: $3,161
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $612 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $315 |
| Janssen Pharmaceuticals, Inc | 6 | $297 |
| Alkermes, Inc. | 11 | $247 |
| ABBVIE INC. | 11 | $228 |
| Otsuka America Pharmaceutical, Inc. | 8 | $201 |
| Lundbeck LLC | 7 | $199 |
| Bausch Health US, LLC | 12 | $175 |
| Neurocrine BioSciences, Inc. | 6 | $174 |
| E.R. Squibb & Sons, L.L.C. | 7 | $163 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, ARISTADA, SPRAVATO, VRAYLAR, INGREZZA, COBENFY.
Industry payments across TX — which companies pay providers there.
